Current challenges that governments face in smoking control

September 14, 2022

Panel Discussion
Wednesday 13:00 - 13:30

Current challenges that governments face in smoking control

There is a growing trend to adopt Harm Reduction Strategies as a complimentary strategy to smoking cessation and smoking prevention that undoubtedly remain the most impactful, cost-effective interventions in medicine. However, due to increasing number of smokers (1.3 billion people worldwide use tobacco products) there is pressure to revisit strategies and evaluate Tobacco Harm Reduction as another pilar of public health strategies. The range between the WHO strategy that rejects all THR products and unrestricted adoption of THR products is vast. THR advocates believe that governments should adopt a pragmatic public health perspective. Should harm reduction strategies be encouraged in smokers who made many efforts but failed to quit? Issues that need to be considered are regulatory framework, taxation, promotion etc. The end goal remains a “smoke free world”.

Moderator: David T. Sweanor J.D.


  • Vassilis Kontozamanis – Greece
  • Karl E. Lund – Norway
  • Sharifa Ezat Wan Puteh – Malaysia
  • Michael G. Toumbis – Cyprus


Chair of the Advisory Board
Centre for Health Law, Policy & Ethics, University of Ottawa


Special Advisor to the Prime Minister of Greece


PhD, Senior Researcher
Norwegian Institute of Public Health


Professor of Hospital Management and Health Economics
Deputy Dean (Relation & Wealth Creation), Faculty of Medicine, UKM Medical Centre; Previous Head of International Centre for Casemix and Clinical Coding (ITCC), UKM Medical Centre


MD, PhD, FCCP, Pneumonologist
President of the Cyprus Institute of Respiratory Diseases